Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-31 Sale |
2025-04-02 5:14 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer |
12,425 | $3.4674 | $43,082 | 194,375 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-03 5:21 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer |
5,421 | $5.5354 | $30,007 | 138,380 (Direct) |
View |
| 2024-09-30 Sale |
2024-10-02 6:50 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer |
11,442 | $3.1952 | $36,559 | 143,801 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 8:00 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
3,881 | $45.25 | $175,615 | 46,720 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 6:07 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
2,821 | $66.62 | $187,935 | 72,838 (Direct) |
View |
| 2022-01-30 Sale |
2022-02-01 1:39 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
1,657 | $66.3 | $109,859 | 36,759 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 7:02 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
359 | $81.14 | $29,129 | 38,416 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-02 6:11 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
5,000 | $100.11 | $500,525 | 147,275 (Direct) |
View |
| 2021-05-06 Sale |
2021-05-10 6:09 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
364 | $113.67 | $41,376 | 38,775 (Direct) |
View |
| 2021-04-15 Sale |
2021-04-19 5:17 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
5,000 | $109.09 | $545,450 | 97,139 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 8:37 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
4,543 | $138.18 | $627,752 | 50,139 (Direct) |
View |
| 2021-01-30 Sale |
2021-02-02 4:28 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
2,243 | $140.36 | $314,827 | 33,546 (Direct) |
View |
| 2021-01-15 Sale |
2021-01-19 4:01 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
25,000 | $139.18 | $3,479,500 | 98,789 (Direct) |
View |
| 2020-10-14 Sale |
2020-10-16 7:22 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
262 | $88 | $23,056 | 35,789 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-06 Option Award |
2025-03-10 8:32 pm |
N/A 2035-03-05 |
Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer |
171,050 | $0 | 309,430 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-25 4:37 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Bedrosian Camille L Director |
3,000 | $0 | 3,000 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-20 9:41 pm |
N/A 2034-06-17 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Bedrosian Camille L Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:19 pm |
N/A 2034-06-07 |
Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director |
15,900 | $0 | 21,900 (Direct) |
View |
| 2024-04-16 Option Award |
2024-04-18 8:19 pm |
N/A 2034-04-15 |
Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer |
216,910 | $0 | 275,243 (Direct) |
View |
| 2023-11-27 Option Award |
2023-11-29 4:49 pm |
N/A 2033-11-26 |
Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer |
220,833 | $0 | 220,833 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:30 pm |
N/A 2033-06-20 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Bedrosian Camille L Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:00 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
2,663 | $0 | 46,720 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 4:44 pm |
N/A 2032-06-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:09 pm |
N/A 2032-06-07 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Bedrosian Camille L Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 6:07 pm |
N/A 2032-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
38,900 | $0 | 72,838 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-02 6:11 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
5,000 | $55 | 147,275 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-02 6:11 pm |
N/A 2028-01-30 |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
5,000 | $0 | 147,275 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:00 pm |
N/A 2031-06-21 |
Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:05 pm |
N/A 2031-06-08 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Bedrosian Camille L Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-04-15 Exercise |
2021-04-19 5:17 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
5,000 | $55 | 97,139 (Direct) |
View |
| 2021-04-15 Exercise |
2021-04-19 5:17 pm |
N/A 2028-01-30 |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
5,000 | $0 | 97,139 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 8:37 pm |
N/A 2031-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
21,136 | $0 | 50,139 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-19 4:01 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
25,000 | $55 | 98,789 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-19 4:01 pm |
N/A 2028-01-30 |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
25,000 | $0 | 98,789 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:11 pm |
N/A 2030-12-08 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Bedrosian Camille L Director |
37,000 | $0 | 37,000 (Direct) |
View |
| 2020-09-01 Option Award |
2020-09-03 5:58 pm |
N/A 2030-08-31 |
Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-05-06 Tax Withholding |
2020-05-08 8:12 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
249 | $66.26 | 36,051 (Direct) |
View |